Hoffmann-La Roche Newswire

Hoffmann-La Roche Newswire

Comprehensive Real-Time News Feed for Hoffmann-La Roche.

Results 1 - 20 of 46 in Hoffmann-La Roche

  1. Biosensors Market Till 2019; SWOT Analysis of Major Market SegmentsRead the original story w/Photo

    Monday Feb 20 | SBWire

    ... the market players in this industry are, Abbott Diagnostics, Roche Diagnostics, Nova Medical, M-Biotech, Hoffmann-La Roche, Medtronic Diabetes, Life sensors Inc., Agamatrix Inc., Bayer Diagnostics and Biacore among others. Contact us: Transparency ...

    Comment?

  2. Global Hematological Malignancies Market Share by Industry Research 2016-2024Read the original story w/Photo

    Friday Feb 17 | SBWire

    ... of untapped opportunities in abundance. AbbVie Inc., Bristol-Myers Squibb Co., Celgene Corp., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. are some of the ...

    Comment?

  3. Biosensors Market : Competitive Dynamics & Global Outlook 2019Read the original story w/Photo

    Friday Feb 17 | PR-inside.com

    ... the market players in this industry are, Abbott Diagnostics, Roche Diagnostics, Nova Medical, M-Biotech, Hoffmann-La Roche, Medtronic Diabetes, Life sensors Inc., Agamatrix Inc., Bayer Diagnostics and Biacore among others. Contact us: Transparency ...

    Comment?

  4. Epidermal Growth Factor Receptor (EGFR) Antibodies Market by...Read the original story w/Photo

    Monday Feb 13 | SBWire

    ... antibodies, Bi- and Multi-specific EGFR antibodies and EGFR antibody drug conjugates. As for instance, Hoffmann-La Roche is performing a phase 1b study of MPDL3280A (and engineered antibody) in combination with Tarceva in patients suffering from ...

    Comment?

  5. Recent Report Covers Upcoming Opportunities in Hemostasis Market Upto 2024Read the original story w/Photo

    Thursday Feb 9 | PR-inside.com

    ... Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Chrono-Log Corporation, and Trinity Biotech plc. US Office Contact 90 State Street, Suite 700 Albany, NY 12207 Tel: ...

    Comment?

  6. Global Colorectal Cancer Market estimated to reach $16.10 billion by 2021Read the original story

    Jan 19, 2017 | Emailwire.com

    According to the report "Global Colorectal Cancer Market", published by Market Data Forecast, the global market is projected to reach USD 16.10 billion by 2021, at a CAGR of 2.60% from 2016 to 2021. Global Colorectal Cancer Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.

    Comment?

  7. At a CAGR of 8.6% Global Solid Tumors Drugs Industry Will Grow Steadily During the Period 2016-2020Read the original story w/Photo

    Jan 17, 2017 | SBWire

    ... years. The report also includes a discussion of the key vendors operating in this market. Key vendors F. Hoffmann-La Roche Novartis Celgene Johnson & Johnson Pfizer BMS Other prominent vendors AbbVie AbGenomics ADC Therapeutics Advantagene Agensys ...

    Comment?

  8. Rapid Medical Diagnostic Kits Market: Asia Pacific Is Expected to...Read the original story w/Photo

    Jan 11, 2017 | SBWire

    The rapid medical diagnostic kits market is experiencing impressive growth globally because of continuous increase in the demand for preventive management of infectious diseases. Since their introduction, rapid medical diagnostic kits are becoming a vital part of the medical diagnostics industry and the scope of this market has been perpetually increasing in terms of detectable diseases and adoption by end users.

    Comment?

  9. Hemostasis Market - Outperformance to Continue due to Rising Global ...Read the original story w/Photo

    Jan 11, 2017 | PR-inside.com

    ... Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Chrono-Log Corporation, and Trinity Biotech plc. US Office Contact 90 State Street, Suite 700 Albany, NY 12207 Tel: ...

    Comment?

  10. Global Diabetic Retinopathy Market Analysis, Size, Share, Growth, Trends and Forecasts to 2021Read the original story

    Jan 10, 2017 | Emailwire.com

    ... The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and ...

    Comment?

  11. Sanofi, Forge $500 Million Autoimmune Diseases Tie-UpRead the original story

    Jan 8, 2017 | BioSpace

    ... partnered with Janssen for the treatment of cancer. Our second product, VISTA agonists, is partnered with Hoffmann-La Roche for the treatment of autoimmune diseases. Other programs include a CD40 agonist for neoantigen cancer vaccines and a novel ...

    Comment?

  12. Hoffmann-La Roche Present on Data Extrapolation at Paediatric Clinical Trials 2017Read the original story

    Dec 4, 2016 | PR.com

    ... incentives and recruitment and retention of patients. Andy Kenwright, Senior Statistical Scientist from Hoffmann-La Roche has recently joined the expert speaker line-up, he will discuss the hot topic of data extrapolation. His presentation will ...

    Comment?

  13. Hoffmann-La Roche present on Data extrapolation at Paediatric Clinical Trials 2017Read the original story w/Photo

    Dec 2, 2016 | PR Log

    ... incentives and recruitment and retention of patients. Andy Kenwright , Senior Statistical Scientist from Hoffmann-La Roche has recently joined the expert speaker line-up, he will discuss the hot topic of data extrapolation. His presentation will ...

    Comment?

  14. Tories call for 'immediate action' to study effects of anti-malarial drugRead the original story w/Photo

    Nov 22, 2016 | Globe and Mail

    ... class-action lawsuit has now been launched against the defence department and pharmaceutical manufacturer Hoffmann-La Roche, on behalf of veterans who say their lives have been ruined by mefloquine. Some of the vets are also asking for the ...

    Comment?

  15. Arix Bioscience Appoints Dr Franz B Humer As Senior Independent DirectorRead the original story

    Oct 30, 2016 | BioSpace

    Dr Humer is one of the pharmaceutical industry's most respected executives. He served as Chief Executive Officer and Chairman of Hoffmann-La Roche and Roche Holding AG over a period of 16 years until 2014.

    Comment?

  16. Arix Bioscience Appoints Dr Franz B Humer as Senior Independent DirectorRead the original story w/Photo

    Oct 31, 2016 | Freshnews

    ... pharmaceutical industry's most respected executives. He served as Chief Executive Officer and Chairman of Hoffmann-La Roche and Roche Holding AG over a period of 16 years until 2014. Dr Humer is currently Chairman of Diageo plc and a Non-Executive ...

    Comment?

  17. Obituary: Luc HoffmannRead the original story w/Photo

    Aug 3, 2016 | The Economist

    ... were thinking that way. What distinguished him was an enormous pot of money. His grandfather had founded Hoffmann-La Roche, and he himself was a majority shareholder in what became a giant pharmaceutical company with annual sales, in this century, ...

    Comment?

  18. A medical school will anchor the mixed-use redevelopment of the former Hoffmann-La Roche campus.Read the original story w/Photo

    Oct 12, 2016 | NorthJersey.com

    The Hoffmann-La Roche campus, part of the Nutley and Clifton communities for about 80 years, has been sold the PB Nutclif I LLC, an affiliate of Bloomfield-based Prism Partners. "Following two full years of comprehensive diligence and complex negotiations involving many stakeholders, the pieces are now in place to move this landmark campus into its next chapter as a preeminent commercial location," Prism Principal Partner Eugene Diaz stated in a press release.

    Comment?

  19. Once bustling with 8,500 employees, Roche waits quietly for next chapterRead the original story w/Photo

    Oct 7, 2016 | The Verona-Cedar Grove Times

    The 116 acres of land on the Clifton and Nutley border that has housed the drug giant Hoffmann-La Roche for about 85 years, will sit quietly until a private medical school and other ventures bring it back to life within the next few years. The land was sold to Prism Capital Partners last week.

    Comment?

  20. Owners of ex-Roche site: 'Measured pace' of changeRead the original story w/Photo

    Oct 7, 2016 | NorthJersey.com

    ... Principal Partners' Eugene R. Diaz and Edwin H. Cohen said they are excited about the future of the former Hoffmann-La Roche campus, bordering Nutley and Clifton. The duo addressed the Nutley Board of Commissioners Tuesday, a few days after ...

    Comment?